The President’s Emergency Program for AIDS Relief is in danger of shuttering. The decision could kill hundreds of thousands of people and kickstart an epidemic.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S.

In dozens of cities, including Milwaukee, the recent rise of fentanyl has put older Black men in particular jeopardy.

Uganda sought to dispel fears among HIV patients that a US aid freeze will interrupt treatment and promised that such ...

The Trump administration's aid freeze affects HIV treatment access. Find out how organizations are coping with the directive.

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

The Trump Administration has ordered the end of distributions of HIV medications purchased with American humanitarian aid.

A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left ...

The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future ...

PEPFAR, a $7.5 billion initiative established in 2003, has provided HIV care to millions worldwide. The recent suspension of the program raised concerns about the potential loss of access to HIV ...

U.S. Secretary of State Marco Rubio will allow access to HIV treatment for people in 55 countries worldwide funded by the U.S ...

But on Tuesday, after public outcry, the Trump administration walked back its ban on distributing HIV medication to patients who need it. Secretary of State Marco Rubio announced that the State ...